As ER signaling was potentiated by the BCSC secretome, it was further investigated if the BCSC secretome modulates the expression of CYCLIN D1 as well as the sensitivity to CDK4/6 inhibitor in breast cancer. The gene discussed is CCND1; the disease is breast carcinoma.